|
[1]BEUERS U, GERSHWIN ME, GISH RG, et al.Changing nomenclature for PBC:from cirrhosis to cholangitis[J].J Hepatol, 2015, 13 (11) :1867-1869.
|
|
[2]SHUAI Z, WANG J, BADAMAGUNTA M, et al.The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitis[J].Hepatology, 2017, 65 (5) :1670-1682.
|
|
[3]European Association for the Study of the Liver.EASL clinical practice guidelines:the diagnosis and management of patients with primary biliary cholangitis[J].J Hepatol, 2017, 67 (1) :145-172.
|
|
[4]DAHLQVIST G, GAOUAR F, CARRAT F, et al.Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis[J].Hepatology, 2017, 65 (1) :152-163.
|
|
[5]CARBONE M, SHARP SJ, FLACK S, et al.The UK-PBC risk scores:derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis[J].Hepatology, 2016, 63 (3) :930-950.
|
|
[6]LAMMERS WJ, HIRSCHFIELD GM, CORPECHOT C, et al.Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy[J].Gastroenterology, 2015, 149 (7) :1804-1812.
|
|
[7]YANG F, YANG Y, WANG Q, et al.The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis:the additional effect of anti-gp210[J].Aliment Pharmacol Ther, 2017, 45 (5) :733-743.
|
|
[8]YANG F, YANG Y, TANG R, et al.Editorial:scoring systems in primary biliary cholangitis-time to make a move.Authors'reply[J].Aliment Pharmacol Ther, 2017, 45 (8) :1164-1165.
|
|
[9]NEVENS F, ANDREONE P, MAZZELLA G, et al.A placebo-controlled trial of obeticholic acid in primary biliary cholangitis[J].N Engl J Med, 2016, 375 (7) :631-643.
|
|
[10]SAMUR S, KLEBANOFF M, BANKEN R, et al.Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis[J].Hepatology, 2017, 65 (3) :920-928.
|
|
[11]WANG Q, YANG F, MIAO Q, et al.The clinical phenotypes of autoimmune hepatitis:a comprehensive review[J].J Autoimmun, 2016, 66:98-107.
|
|
[12]YANG F, WANG Q, WANG Z, et al.The natural history and prognosis of primary biliary cirrhosis with clinical features of autoimmune hepatitis[J].Clin Rev Allergy Immunol, 2016, 50 (1) :114-123.
|
|
[13]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and management of primary biliary cirrhosis (cholangitis) (2015) [J].J Clin Hepatol, 2015, 31 (12) :1980-1988. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.原发性胆汁性肝硬化 (又名原发性胆汁性胆管炎) 诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2015, 31 (12) :1980-1988.
|
DownLoad: